查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
北美孕产妇心理健康市场规模、份额和趋势分析报告：按适应症、治疗方法、地区和细分趋势：2023-2030
市场调查报告书
商品编码
1321390

北美孕产妇心理健康市场规模、份额和趋势分析报告：按适应症、治疗方法、地区和细分趋势：2023-2030

North America Maternal Mental Health Market Size, Share & Trends Analysis Report By Disease Indication (Postpartum Depression, Dysthymia), By Therapy (Interpersonal Psychotherapy, Antidepressants), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

北美孕产妇心理健康市场的增长和趋势

Grand View Research, Inc.最新报告显示，到2030年，北美孕产妇心理健康市场规模预计将达到206.3亿美元，2023年至2030年年复合成长率为29.68%。

近年来，由于努力提高认识、改进筛查和评估以及增加获得护理的机会，美国孕产妇心理健康行业持续增长。然而，差距依然存在，不仅在获取机会方面，而且在对弱势群体的心理健康支持方面也存在差距。加拿大政府已实施法规并提供资金来解决孕产妇心理健康问题。

这包括通过就业保险计划提供产假福利、心理健康战略、为围产期心理健康服务提供资金、协作护理模式、研究和资料收集以及对社区组织的支持等倡议。这些倡议旨在改善加拿大各地孕妇和新妈妈获得心理健康服务和支持的机会。此外，威斯康星州卫生服务部 (DHS) 于 2022 年 10 月宣布，将提供总计 1600 万美元用于促进孕产妇和儿童健康。这笔资金将通过与威斯康星医学院推进健康威斯康星捐赠基金和威斯康星大学医学与公共卫生学院合作，用于减少孕产妇和儿童健康结果的差异。

此外，该计划还将向国土安全部妇幼健康计划提供资金，以管理赠款计划。该计划资助促进孕产妇和儿童健康公平的努力，以降低孕产妇和婴儿死亡率并改善威斯康星州家庭的生活状况。每个合作伙伴将获得550万美元的项目支持。增加的资金将使政府能够查明每名孕产妇死亡的确切原因。然后，政府将能够在医院和其他分娩设施中扩大和实施以接待为基础的计划，以解决导致孕产妇健康状况不佳的根本问题。

15% 的新妈妈罹患产后抑郁症，但往往被耻辱、社会期望和缺乏医学知识所掩盖。儘管存在与精神疾病相关的耻辱，但女性正在利用可接受的文化运动来结构她们的产后抑郁症经历，课题传统的母性观念，并承认她们的痛苦。她们通过成功地完成任务，表现出了聪明才智和韧性。在美国，产后抑郁症的社会耻辱是一个严重的问题。因此，一些女性不愿意寻求产后抑郁症治疗，因为她们担心受到污名化或耻辱。

北美孕产妇心理健康市场报告亮点

  • 2022年，妊娠及产后广泛性焦虑领域将占比最大。对包括焦虑症在内的围产期精神状态问题的认识和认识的提高是推动该细分市场增长的主要要素。
  • 由于有利的报销方案、筛查意识的提高以及新疗法的批准，预计 PPD 领域从 2023 年到 2030 年将实现良好的年复合成长率。
  • 2022年，IPT占据市场主导地位，因为它被认为是治疗各种精神疾病的有效疗法。
  • 由于政府资金雄厚、研究力度加大以及领先公司的存在等要素，美国在该地区占据市场领先地位。

目录

第1章调查方法和范围

  • 市场区隔
  • 目的
  • 调查方法
  • 资讯采购
    • 购买数据库
    • GVR内部数据库
    • 次要资讯
    • 初步调查
  • 资讯或资料分析
    • 资料分析模型
  • 市场形成和检验
  • 型号详情
    • 产品流向分析
  • 二手资讯清单
  • 简称列表
  • 主要资讯清单

第2章执行摘要

第3章北美孕产妇心理健康市场变量和趋势

  • 市场体系预测
    • 母市场预测
  • 市场动态
    • 市场促进因素影响分析
    • 市场限制的影响分析
  • COVID-19 大流行的影响
  • 行业分析工具
    • 波特的分析
    • SWOT 分析：要素因素（政治/法律、经济/技术）

第4章北美孕产妇心理健康市场：按适应症分类的估算及趋势分析

  • 2022 年和 2030 年按适应症分類的波动分析和市场份额
  • 按疾病分类
  • 产后抑郁症
  • 调变
  • 常见的怀孕和产后焦虑
  • 怀孕和产后强迫症
  • 与出生有关的创伤后应激障碍
  • 其他的

第5章北美孕产妇心理健康市场：按治疗方法的估计和趋势分析

  • 2022 年和 2030 年各疗法的变异分析和市场份额
  • 通过治疗
  • 抗抑郁药
    • 2018年至2030年全球抗抑郁药市场估计和预测
    • 选择性血清素再回收抑制剂（SSRI）
    • 三环类抗抑郁药（TCA）
    • 其他的
  • 人际心理治疗（IPT）
  • 认知行为疗法（CBT）
  • 其他的

第6章北美孕产妇心理健康市场：区域估计和趋势分析

  • 北美孕产妇心理健康市场：区域预测
  • 北美
    • 2018年至2030年北美孕产妇心理健康市场估计和预测
    • 美国
    • 加拿大

第7章北美孕产妇心理健康市场：竞争形势

  • 参与企业
    • Therapy Mama
    • Canopie
    • Pfizer Inc
    • Viatris Inc.
    • GlaxoSmithKline Inc.
    • Alembic Pharmaceuticals Limited
    • Mallinckrodt Inc.
    • Sage Therapeutics, Inc.
    • Bausch Health Companies Inc.
    • Magellan Health, Inc.
  • 参与企业概况
  • 财务绩效
  • 产品对标
  • 2022 年公司市场份额分析
  • 战略规划
    • 扩张
    • 获得
    • 产品/服务发布
    • 其他的

第8章分析师的观点

Product Code: GVR-4-68040-097-8

North America Maternal Mental Health Market Growth & Trends

The North America maternal mental health market size is expected to reach USD 20.63 billion by 2030, growing at a CAGR of 29.68% from 2023 to 2030, according to a new report by Grand View Research, Inc. The maternal mental health industry in the U.S. has been growing in recent years, with increased awareness, improved screening and assessment, and efforts to enhance access to care. However, disparities in access as well as gaps in mental well-being support for vulnerable populations still exist. The Canadian government has implemented regulations and provided funding to address maternal mental conditions.

These include initiatives such as maternity leave benefits under the Employment Insurance program, mental well-being strategies, funding for perinatal mental health services, collaborative care models, research and data collection, and support for community-based organizations. These efforts aim to improve access to mental well-being services and support for pregnant women and new mothers across Canada. Moreover, the Wisconsin Department of Health Services (DHS) announced awards totaling USD 16 million in October 2022 to enhance maternal and child health. The funds will be invested to close maternal and child health outcomes gaps through collaborations with the Medical College of Wisconsin's Advancing a Healthier Wisconsin Endowment and the University of Wisconsin School of Medicine and Public Health.

In addition, this initiative offers funding to DHS Maternal and Child Health Program to manage a grant program. This program will provide funding for initiatives that promote maternal and child health equity to reduce maternal and infant mortality at the systemic and community levels and improve outcomes for families throughout Wisconsin. Each partner will receive USD 5.5 million to help them with their projects. With the help of increased funds, the government can determine the precise causes of each maternal mortality. The government will then be able to extend and implement evidence-based programs in hospitals and other birthing facilities to deal with the fundamental problems that result in poor maternal condition outcomes.

Although postnatal depression affects 15% of new mothers, it is frequently masked by stigma, societal expectations, and lack of medical knowledge. Despite the stigmatizing nature of mental illness, women have shown ingenuity and resilience by using acceptable cultural movements to reframe their experiences of PPD, challenging conventional views of motherhood, and successfully gaining recognition of their sufferings. The social stigma associated with PPD is a serious problem in the U.S. Many people think PPD is an unreal ailment or a sign of weakness. Therefore, some women might hesitate to seek treatment for PPD out of concern that they would be stigmatized or condemned.

North America Maternal Mental Health Market Report Highlights

  • The pregnancy and postpartum general anxiety segment accounted for the largest share in 2022. Increasing awareness and recognition of perinatal mental condition issues including anxiety disorders is the major factor driving the segment growth
  • The PPD segment is expected to witness a lucrative CAGR through 2023 - 2030 owing to the favorable reimbursement scenario, increasing awareness for screening, and approval of novel therapies
  • IPT dominated the market in 2022 as IPT is considered an effective therapy for treating a variety of mental conditions
  • The U.S. led the regional market due to factors contributing such as robust government funding, increasing research, and the presence of prominent players

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation
    • 1.1.1. Market Definitions
  • 1.2. Objectives
    • 1.2.1. Objective - 1
    • 1.2.2. Objective - 2
    • 1.2.3. Objective - 3
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. Gvr's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Disease Indication and Therapy Snapshot 1
  • 2.3. Competitive Landscape Snapshot

Chapter 3. North America Maternal Mental Health Market Variables and Trends

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Impact Analysis
      • 3.2.1.1. Rise in government funding to reduce the maternal mortality
      • 3.2.1.2. Increasing incidence of post-partum depression
      • 3.2.1.3. Rise in awareness programs and efforts to improve practices around maternal mental healthcare
    • 3.2.2. Market Restraint Impact Analysis
      • 3.2.2.1. Mental health workforce shortage
      • 3.2.2.2. Social stigma surrounding postpartum depression
  • 3.3. Impact of the COVID-19 Pandemic
  • 3.4. Industry Analysis Tools
    • 3.4.1. Porter's Analysis
    • 3.4.2. Swot Analysis; By Factor (Political & Legal, Economic And Technological)

Chapter 4. North America Maternal Mental Health Market: Disease Indication Estimates & Trend Analysis

  • 4.1. Disease Indication Movement Analysis & Market Share, 2022 & 2030
  • 4.2. North America Maternal Mental Health Market Estimates & Forecast, By Disease Indication (USD Million)
  • 4.3. Postpartum Depression
    • 4.3.1. Global Postpartum Depression Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Dysthymia
    • 4.4.1. Global Dysthymia Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Pregnancy and Postpartum General Anxiety
    • 4.5.1. Global Pregnancy And Postpartum General Anxiety Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Pregnancy and Postpartum OCD
    • 4.6.1. Global Pregnancy And Postpartum OCD Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Birth-Related PTSD
    • 4.7.1. Global Birth-Related PTSD Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Global Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 5. North America Maternal Mental Health Market: Therapy Estimates & Trend Analysis

  • 5.1. Therapy Movement Analysis & Market Share, 2022 & 2030
  • 5.2. North America Maternal Mental Health Market Estimates & Forecast, By Therapy (USD Million)
  • 5.3. Antidepressants
    • 5.3.1. Global Antidepressants Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. Selective Serotonin Reuptake Inhibitors (SSRIs)
      • 5.3.2.1. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.3.3. Tricyclic Antidepressants (TCAs)
      • 5.3.3.1. Global Tricyclic Antidepressants (TCAs) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.3.4. Others
      • 5.3.4.1. Global Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Interpersonal Psychotherapy (IPT)
    • 5.4.1. Global Interpersonal Psychotherapy (IPT) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Cognitive Behavioral Therapy (CBT)
    • 5.5.1. Global Cognitive Behavioral Therapy (CBT) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Global Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 6. North America Maternal Mental Health Market: Regional Estimates and Trend Analysis

  • 6.1. North America Maternal Mental Health Market: Regional Outlook
  • 6.2. North America
    • 6.2.1. North America Maternal Mental Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. Key Country Dynamics
      • 6.2.2.2. Competitive Scenario
      • 6.2.2.3. Regulatory Framework
      • 6.2.2.4. U.S. North America Maternal Mental Health Market Estimates and Forecasts, 2018 - 2030 (USD MILLION)
    • 6.2.3. Canada
      • 6.2.3.1. Key Country Dynamics
      • 6.2.3.2. Competitive Scenario
      • 6.2.3.3. Regulatory Framework
      • 6.2.3.4. Canada North America Maternal Mental Health Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. North America Maternal Mental Health Market: Competitive Landscape

  • 7.1. Participant Categorization
    • 7.1.1. Therapy Mama
      • 7.1.1.1. Overview
      • 7.1.1.2. Product Benchmarking
      • 7.1.1.3. Strategic Initiatives
    • 7.1.2. Canopie
      • 7.1.2.1. Overview
      • 7.1.2.2. Product Benchmarking
      • 7.1.2.3. Strategic Initiatives
    • 7.1.3. Pfizer Inc
      • 7.1.3.1. Overview
      • 7.1.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.1.3.3. Product Benchmarking
      • 7.1.3.4. Strategic Initiatives
    • 7.1.4. Viatris Inc.
      • 7.1.4.1. Overview
      • 7.1.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.1.4.3. Product Benchmarking
      • 7.1.4.4. Strategic Initiatives
    • 7.1.5. GlaxoSmithKline Inc.
      • 7.1.5.1. Overview
      • 7.1.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.1.5.3. Product Benchmarking
      • 7.1.5.4. Strategic Initiatives
    • 7.1.6. Alembic Pharmaceuticals Limited
      • 7.1.6.1. Overview
      • 7.1.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.1.6.3. Product Benchmarking
      • 7.1.6.4. Strategic Initiatives
    • 7.1.7. Mallinckrodt Inc.
      • 7.1.7.1. Overview
      • 7.1.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.1.7.3. Product Benchmarking
      • 7.1.7.4. Strategic Initiatives
    • 7.1.8. Sage Therapeutics, Inc.
      • 7.1.8.1. Overview
      • 7.1.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.1.8.3. Product Benchmarking
      • 7.1.8.4. Strategic Initiatives
    • 7.1.9. Bausch Health Companies Inc.
      • 7.1.9.1. Overview
      • 7.1.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.1.9.3. Product Benchmarking
      • 7.1.9.4. Strategic Initiatives
    • 7.1.10. Magellan Health, Inc.
      • 7.1.10.1. Overview
      • 7.1.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.1.10.3. Product Benchmarking
      • 7.1.10.4. Strategic Initiatives
  • 7.2. Participant's Overview
  • 7.3. Financial Performance
  • 7.4. Product Benchmarking
  • 7.5. Company Market Share Analysis, 2022
  • 7.6. Strategy Mapping
    • 7.6.1. Expansion
    • 7.6.2. Acquisition
    • 7.6.3. Product/Service Launch
    • 7.6.4. Others

Chapter 8. Analyst View

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of Abbreviations
  • Table 3 North America maternal mental health market, by region, 2018 - 2030 (USD Million)
  • Table 4 North America maternal mental health market, by disease indication, 2018 - 2030 (USD Million)
  • Table 5 North America maternal mental health market, by therapy, 2018 - 2030 (USD Million)
  • Table 6 North America maternal mental health market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America maternal mental health market, by disease indication, 2018 - 2030 (USD Million)
  • Table 8 North America maternal mental health market, by therapy, 2018 - 2030 (USD Million)
  • Table 9 U.S. maternal mental health market, by disease indication, 2018 - 2030 (USD Million)
  • Table 10 U.S. maternal mental health market, by therapy, 2018 - 2030 (USD Million)
  • Table 11 Canada maternal mental health market, by disease indication, 2018 - 2030 (USD Million)
  • Table 12 Canada maternal mental health market, by therapy, 2018 - 2030 (USD Million)
  • Table 13 Company Overview
  • Table 14 Financial Performance
  • Table 15 Product Benchmarking
  • Table 16 Strategic Initiatives

List of Figures

  • Fig. 1 Maternal Mental Health market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation

Fig. 9 Market Outlook (2022)

  • Fig. 10 Segment Outlook
  • Fig. 11 Strategy framework
  • Fig. 12 Market driver relevance analysis (current & future impact)
  • Fig. 13 Market restraint relevance analysis (current & future impact)
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 Swot analysis, by factor (political & legal, economic and technological)
  • Fig. 16 North America maternal mental health market: disease indication movement analysis
  • Fig. 17 North America maternal mental health market, for postpartum depression, 2018 - 2030 (USD million)
  • Fig. 18 North America maternal mental health market, for dysthymia, 2018 - 2030 (USD million)
  • Fig. 19 North America maternal mental health market, for pregnancy and postpartum general anxiety, 2018 - 2030 (USD million)
  • Fig. 20 North America maternal mental health market, for pregnancy and postpartum OCD, 2018 - 2030 (USD million)
  • Fig. 21 North America maternal mental health market, for birth-related PTSD, 2018 - 2030 (USD million)
  • Fig. 22 North America maternal mental health market, for others, 2018 - 2030 (USD million)
  • Fig. 23 North America maternal mental health market: therapy movement analysis
  • Fig. 24 North America maternal mental health market, for antidepressants, 2018 - 2030 (USD million)
  • Fig. 25 North America maternal mental health market, for selective serotonin reuptake inhibitors, 2018 - 2030 (USD million)
  • Fig. 26 North America maternal mental health market, for tricyclic antidepressants, 2018 - 2030 (USD million)
  • Fig. 27 North America maternal mental health market, for others, 2018 - 2030 (USD million)
  • Fig. 28 North America maternal mental health market, for interpersonal psychotherapy, 2018 - 2030 (USD million)
  • Fig. 29 North America maternal mental health market, for cognitive behavioral therapy, 2018 - 2030 (USD million)
  • Fig. 30 North America maternal mental health market, for others, 2018 - 2030 (USD million)
  • Fig. 31 Regional marketplace: key takeaways
  • Fig. 32 Regional outlook, 2022 & 2030
  • Fig. 33 North America maternal mental health market: region movement analysis
  • Fig. 34 North America maternal mental health market, 2018 - 2030 (USD million)
  • Fig. 35 U.S. Maternal mental health market, 2018 - 2030 (USD million)
  • Fig. 36 Canada maternal mental health market, 2018 - 2030 (USD million)